Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-11-008395
Filing Date
2011-11-10
Accepted
2011-11-10 14:04:52
Documents
11
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q govx_10q-093011.htm 10-Q 444853
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 16271
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 16533
4 EXHIBIT 32.1 ex32-1.htm EX-32.1 6301
5 EXHIBIT 32.2 ex32-2.htm EX-32.2 6488
  Complete submission text file 0001437749-11-008395.txt   1390223

Data Files

Seq Description Document Type Size
6 govx-20110930.xml EX-101.INS 106629
7 govx-20110930.xsd EX-101.SCH 13521
8 govx-20110930_cal.xml EX-101.CAL 20599
9 govx-20110930_def.xml EX-101.DEF 58903
10 govx-20110930_lab.xml EX-101.LAB 86541
11 govx-20110930_pre.xml EX-101.PRE 67413
Mailing Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA 2Q 30080
Business Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA 2Q 30080 678-384-7220
GeoVax Labs, Inc. (Filer) CIK: 0000832489 (see all company filings)

EIN.: 870455038 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52091 | Film No.: 111194625
SIC: 8731 Services-Commercial Physical & Biological Research